AMLX icon

Amylyx Pharmaceuticals

120 hedge funds and large institutions have $188M invested in Amylyx Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
+11
Holders Change %
+10.09%
% of All Funds
1.6%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
35
Reduced
39
Closed
20
Calls
$1.36M
Puts
$1.94M
Net Calls
-$579K
Net Calls Change
+$1.67M
Name Holding Trade Value Shares
Change
Shares
Change %
AG
126
Algert Global
California
-$344K -106,219 Closed
HF
127
HRT Financial
New York
-$263K -81,291 Closed
GCM
128
Graham Capital Management
Connecticut
-$220K -67,956 Closed
SC
129
Savant Capital
Illinois
-$187K -57,565 Closed
LA
130
Legacy Advisors
Pennsylvania
-$162K -50,000 Closed
Bank of New York Mellon
131
Bank of New York Mellon
New York
-$76.7K -23,679 Closed
PPWP
132
Premier Path Wealth Partners
New Jersey
-$65.7K -20,265 Closed
AWM
133
Aries Wealth Management
Maine
-$48.6K -15,000 Closed
CC
134
Corton Capital
Ontario, Canada
-$42.5K -13,104 Closed
BCM
135
Bayesian Capital Management
New York
-$34.7K -10,700 Closed
AWS
136
Atria Wealth Solutions
New York
-$32.4K -10,000 Closed
CFM
137
Catalyst Funds Management
Australia
-$24.3K -7,500 Closed
BTI
138
Blue Trust Inc
Georgia
-$4K -2,104 Closed
NC
139
nVerses Capital
Florida
-$6.8K -2,100 Closed
Point72 Asset Management
140
Point72 Asset Management
Connecticut
-$648 -200 Closed